Services

Commercial API - Locations & Capabilities

Torcan (Toronto) site (Canada)

The site has flexible GMP pilot plants for carrying out a number of reaction systems, is equipped with high pressure hydrogenation and can carry out cryogenic reactions upto -75 deg C.

The site can supply niche APIs with batch sizes of upto 2000 litres.

Morpeth and Huddersfield sites (UK)

Manufacturing of advanced intermediates is routinely carried out at the Huddersfield site and API finishing in Class 10,000 environment is carried out at the Morpeth site.

The Huddersfield site has reactor systems with scales upto 6300L and can handle borohydride chemistry, toxic fumes and gases etc. The Morpeth site has reactor systems upto 2000 litres for final stages processing of APIs.

Grangemouth site (UK)

The Grangemouth site manufactures High Potency APIs, including cytotoxics. The site has a dedicated suite for manufacture of high potency prostaglandins upto 0.6Kg batch size scales.

The site has GMP suites with glove box systems that can handle Safebridge Category 4 APIs conveniently. Reactor sizes upto 600 litres can be configures in the suites for supply of niche High Potency or Cytotoxic APIs

Digwal Site (India)

The Digwal site is Pharma Solutions’s flagship site for supply of commercial APIs. The site has 8 production blocks with over 130 reaction vessels and a total reaction volume of 430,000L.

The site has been expanded a number of times over the years and can handle reaction systems as Hydrogenation, commercial LiAH and BuLi etc. API finishing is carried out in Class 100,000 environment and powder processing equipment is available.

The Digwal site has been audited by the USFDA a number of times without any 483s